![Rene Belder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rene Belder
Plus aucun poste en cours
Profil
Rene Belder has been Vice President of Clinical and Regulatory Affairs for Pharmacopeia, Inc. since November 2006 and joined BMS in 1987.
He had been Vice President of Development Champion for BMS since 2003 and was an Executive Director of Clinical Research and Life Cycle Management from 1999 to 2003.
Dr. Belder received an MD from the Medical School at Erasmus University of Rotterdam.
Anciens postes connus de Rene Belder
Sociétés | Poste | Fin |
---|---|---|
Pharmacopeia LLC
![]() Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Directeur Technique/Scientifique/R&D | 28/11/2012 |
Formation de Rene Belder
Erasmus University Rotterdam | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Pharmacopeia LLC
![]() Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |